Single Use Assemblies

Single Use Assemblies

Global Single Use Assemblies Market to Reach US$17.2 Billion by 2030

The global market for Single Use Assemblies estimated at US$4.7 Billion in the year 2023, is expected to reach US$17.2 Billion by 2030, growing at a CAGR of 20.2% over the analysis period 2023-2030. Bag Assemblies, one of the segments analyzed in the report, is expected to record a 23.9% CAGR and reach US$8.8 Billion by the end of the analysis period. Growth in the Filtration Assemblies segment is estimated at 19.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 26.3% CAGR

The Single Use Assemblies market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2030 trailing a CAGR of 26.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.7% and 18.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.7% CAGR.

Global Single Use Assemblies Market - Key Trends and Drivers Summarized

How Are Single Use Assemblies Revolutionizing Biopharmaceutical Manufacturing?

Single use assemblies (SUA) are pre-assembled, disposable systems used in biopharmaceutical manufacturing, replacing traditional stainless-steel systems for fluid management, mixing, filtration, and storage. These assemblies include components like tubing, connectors, filters, and bioprocess containers, designed to be used once and then discarded. By eliminating the need for cleaning, sterilization, and validation, single use assemblies reduce contamination risks, accelerate production timelines, and enhance flexibility in bioprocessing. As the biopharmaceutical industry shifts toward more agile and scalable manufacturing processes, single use assemblies have become essential for both clinical production and commercial-scale operations.

What Are the Key Segments in the Single Use Assemblies Market?

Major products include bag assemblies, filtration assemblies, bottle assemblies, and mixing system assemblies, with bag assemblies holding the largest share due to their extensive use in fluid storage and handling. Key applications cover filtration, cell culture, mixing, and storage, with filtration representing a significant segment as it is critical in ensuring product purity and quality. End-users include biopharmaceutical companies, contract manufacturing organizations (CMOs), and research institutes, with biopharmaceutical companies leading the market due to their focus on flexible and efficient production processes.

How Are Single Use Assemblies Integrated Across Biopharmaceutical Manufacturing?

In biopharmaceutical manufacturing, single use assemblies are used in upstream and downstream processes, from cell culture to final product formulation, providing a sterile environment for fluid management. In upstream processing, single use bag assemblies are employed for media preparation, mixing, and fermentation, ensuring contamination-free growth of cell cultures. Downstream processes utilize single use filtration and purification assemblies for product recovery and concentration, enhancing product quality and yield. Contract manufacturing organizations (CMOs) adopt single use assemblies to provide flexible production capacity for clinical trials and commercial production, reducing turnaround times and operational costs. Additionally, single use assemblies are increasingly used in vaccine production, where rapid scalability and sterility are essential.

What Factors Are Driving the Growth in the Single Use Assemblies Market?

The growth in the Single Use Assemblies market is driven by several factors, including the expanding biopharmaceutical sector, which demands flexible, scalable, and contamination-free manufacturing solutions. The growing prevalence of biologics, biosimilars, and personalized medicine has accelerated the adoption of single use technologies, including single use assemblies. Advancements in bioprocessing technology, such as improved materials and integration with automation, have enhanced the reliability and efficiency of single use assemblies. The increasing focus on reducing operational costs, minimizing contamination risks, and accelerating production timelines has further fueled demand. Additionally, government support for vaccine production and biopharmaceutical innovation has contributed to the wider adoption of single use assemblies across the industry.

Select Competitors (Total 42 Featured) -

• Avantor
• Charter Medical
• Colder Products Company
• Cole Parmer
• Corning
• Danaher
• Entegris
• Flexbiosys
• Foxx Life Sciences
• GE Healthcare
• Intellitech
• Keofitt
• Lonza
• Meissner
• Merck Millipore
• NewAge Industries
• Parker Hannifin
• Repligen
• Romynox
• Saint-Gobain
• SaniSure
• Sartorius Stedim Biotech
• TBL Performance Plastics
• Thermo Fisher Scientific
• WHK BioSystems

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.